88260-08-6

Usage

Structure

It has a bicyclic structure containing a nitrogen atom.

Application

Organic Synthesis: Used as a building block for creating new molecules.
Pharmaceutical Research: Investigated for potential drug development.

Biological Activities

Being studied for potential therapeutic applications.

Reference Standard

Used in analytical testing and quality control in various industries.

Versatility

Widely applicable in chemistry, biology, and medicine.

Upstream product

• 89768-07-0 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid ethyl ester hydrochloride 

Downstream Products

• 529478-33-9 ethyl 2-(4-methoxybenzoyl)-2-azabicyclo[2.2.1]heptane-3-carboxylate 
• 529478-35-1 ethyl 2-(4-methoxybenzyl)-2-azabicyclo[2.2.1]heptane-3-carboxylate 
• 385807-10-3 (5α,8α,8aβ)-Tetrahydro-2-[3-(trifluoromethyl)phenyl]-5,8-methanoimidazo[1,5-a]pyridine-1,3(2H,5H)-dione 
• 291775-53-6 (1S,3R,4R)-N-tert-butoxycarbonyl-2-azabicyclo[2.2.1]heptane-3-carboxylic acid 
• 1033766-04-9 N-{3-[3-(4-fluorobenzyl)-6-hydroxy-4-oxo-2,3-diaza-tricyclo[6.2.1.02,7]undec-5-en-5-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}methanesulfonamide 
• 1033766-30-1 2-(4-fluoro-benzylamino)-2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

FUSED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

Provided are fused tricyclic compounds effective to inhibit the function of the NS5A protein of formula (I), wherein X, X', Y, Y', A, A',Q1, Q2, R1-R4, X4, R5a, f and W are defined as in the description. Also provided herein are pharmaceutical compositions thereof, and uses in the manufacture of a medicament for treating HCV infection or a HCV disorder thereof.

SATURATED FUSED [1,2-B] PYRIDAZINONE COMPOUNDS

The invention is directed to saturated fused [1,2-b]pyridazinone compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.

AZABICYCLO COMPOUND, MATRIX METALLOPROTEASE INHIBITOR, AND SKIN PREPARATION

An azabicyclo compound (I) or a salt thereof in accordance with the present invention has an excellent inhibiting action on matrix metalloproteases (MMPs) activity, and is useful for pharmaceutical, cosmetic and skin external compositions. wherein R is H,